- Home
- ISRG vs PFE Comparison
ISRG vs PFE Comparison
Compare ISRG & PFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISRG
- PFE
- Stock Information
- Founded
- ISRG 1995
- PFE 1849
- Country
- ISRG United States
- PFE United States
- Employees
- ISRG N/A
- PFE N/A
- Industry
- ISRG Medical/Dental Instruments
- PFE Biotechnology: Pharmaceutical Preparations
- Sector
- ISRG Health Care
- PFE Health Care
- Exchange
- ISRG Nasdaq
- PFE Nasdaq
- Market Cap
- ISRG 191.1B
- PFE 166.8B
- IPO Year
- ISRG 2000
- PFE N/A
- Fundamental
- Price
- ISRG $547.87
- PFE $25.63
- Analyst Decision
- ISRG Buy
- PFE Buy
- Analyst Count
- ISRG 21
- PFE 13
- Target Price
- ISRG $506.60
- PFE $33.17
- AVG Volume (30 Days)
- ISRG 1.3M
- PFE 55.0M
- Earning Date
- ISRG 01-21-2025
- PFE 10-29-2024
- Dividend Yield
- ISRG N/A
- PFE 6.55%
- EPS Growth
- ISRG 46.29
- PFE N/A
- EPS
- ISRG 6.22
- PFE 0.74
- Revenue
- ISRG $7,866,900,000.00
- PFE $59,375,000,000.00
- Revenue This Year
- ISRG $16.63
- PFE $8.76
- Revenue Next Year
- ISRG $16.89
- PFE $0.37
- P/E Ratio
- ISRG $88.12
- PFE $34.46
- Revenue Growth
- ISRG 14.83
- PFE N/A
- 52 Week Low
- ISRG $304.50
- PFE $24.48
- 52 Week High
- ISRG $552.00
- PFE $31.54
- Technical
- Relative Strength Index (RSI)
- ISRG 68.80
- PFE 36.44
- Support Level
- ISRG $526.01
- PFE $24.61
- Resistance Level
- ISRG $544.38
- PFE $26.85
- Average True Range (ATR)
- ISRG 10.54
- PFE 0.62
- MACD
- ISRG 1.09
- PFE -0.11
- Stochastic Oscillator
- ISRG 90.96
- PFE 32.67
About ISRG Intuitive Surgical Inc.
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 8,600 da Vinci systems in hospitals worldwide, with more than 5,000 installations in the US and a growing number in emerging markets.
About PFE Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.